Monopar Therapeutics (NASDAQ:MNPR) prices its IPO of 1,111,112 common shares at $8/share.
Underwriters have an option to purchase up to an additional 166,666 shares.
Trading commences today.
Closing date is December 23, 2019.
Source: Press Release
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.